UDCA, NorUDCA, and TUDCA in Liver Diseases: A Review of Their Mechanisms of Action and Clinical Applications
Authors:
- 25 June 2019
- book chapter
- Published by Springer Nature
- Vol. 256, 237-264
Abstract
Bile acids (BAs) are key molecules in generating bile flow, which is an essential function of the liver. In the last decades, there have been great advances in the understanding of BA physiology, and new insights have emerged regarding the role of BAs in determining cell damage and death in several liver diseases. This new knowledge has helped to better delineate the pathophysiology of cholestasis and the adaptive responses of hepatocytes to cholestatic liver injury as well as of the mechanisms of injury of biliary epithelia. In this context, therapeutic approaches for liver diseases using hydrophilic BA (i.e., ursodeoxycholic acid, tauroursodeoxycholic, and, more recently, norursodeoxycholic acid), have been revamped. In the present review, we summarize current experimental and clinical data regarding these BAs and its role in the treatment of certain liver diseases.Keywords
This publication has 163 references indexed in Scilit:
- Bile acid transporters and regulatory nuclear receptors in the liver and beyondJournal of Hepatology, 2013
- Strong activation of bile acid-sensitive ion channel (BASIC) by ursodeoxycholic acidChannels, 2013
- Therapy of gallstone disease: What it was, what it is, what it will beWorld Journal of Gastrointestinal Pharmacology and Therapeutics, 2012
- Ursodeoxycholic Acid Is Conjugated with Taurine to Promote Secretin-Stimulated Biliary Hydrocholeresis in the Normal RatPLOS ONE, 2011
- Bile acids: regulation of apoptosis by ursodeoxycholic acidJournal of Lipid Research, 2009
- Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2 −/− mice†‡§Hepatology, 2009
- Fifty years of advances in bile acid synthesis and metabolismJournal of Lipid Research, 2009
- The role of membrane cholesterol in determining bile acid cytotoxicity and cytoprotection of ursodeoxycholic acidBiochimica et Biophysica Acta (BBA) - Biomembranes, 2009
- Drug Insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasisNature Clinical Practice Gastroenterology & Hepatology, 2006
- Clinical Pharmacokinetics of Therapeutic Bile AcidsClinical Pharmacokinetics, 1996